0
0.5
1
1.5
2+
Hospitalization
69%
Improvement
Relative Risk
Time to sustained clinical..
9%
Time to sustained clin.. (b)
35%
Viral clearance
43%
Nigella Sativa Bencheqroun et al. EARLY TREATMENT DB RCT
Is early treatment with nigella sativa beneficial for COVID-19?
Double-blind RCT 52 patients in the USA (May - September 2021)
Lower hospitalization (p=0.44) and improved viral clearance (p=0.31), not sig.
c19early.org
Bencheqroun et al., Pathogens, May 2022
Favors nigella sativa
Favors control